Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclizumab and Denileukin Diftitox for Uveitis Immune Tolerance
NCT00326508Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- May 2006
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of denileukin diftitox in non-infectious intermediate uveitis, Posterior uveitis (non-infectious), sponsored by National Eye Institute. Started May 2006; status: completed.
02
Drugs
denileukin diftitox
03
Conditions
non-infectious intermediate uveitisPosterior uveitis (non-infectious)
Beyond the preview
Go deeper on NCT00326508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00326508.